Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $146.4300 (5%) ($146.4300 - $146.4300) on Thu. Oct. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 87 | Latest Price | $146.4300(5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.1% a day on average for past five trading days. | Weekly Trend | LGND advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(57%) IWC(54%) IWN(53%) | Factors Impacting LGND price | LGND will decline at least -1.495% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-5%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 2.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $139.84(4.71%) | 10 Day Moving Average | $135.57(8.01%) | 20 Day Moving Average | $132.48(10.53%) | To recent high | 0% | To recent low | 42.9% | Market Cap | $2.353b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |